Solitaire -Model X -Revascularization Device for Acute Ischemic Stroke
The Solitaire X revascularization device, featuring Parametric™ design, a unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO).
UNIQUE PARAMETRIC DESIGN
FOR DYNAMIC CLOT INTEGRATION2
The overlapping stent design allows the device to expand in larger vessels and compress in smaller vessels during deployment and retrieval3 as well as:
- Maintaining consistent stent cell size and structure8
- Differentiated radial outward force4,5
- Providing multiple planes of clot integration contact3
FOR IMPROVED EFFICIENCY1,7
Our Solitaire X Revascularization Device — designed with an optimized delivery system — produces lower delivery force7 for improved procedural efficiency and smooth navigation through even the most complicated anatomy.
WITH COVERAGE FROM M2 TO ICA4,6
The distinctive, evenly-spaced platinum markers let you visualize the optimal working length and stent behavior for real-time procedural feedback, ensuring accurate alignment, optimal revascularization, and clot capture success.2
The 6x40 length device simplifies placement with proximal ophthalmic alignment, providing complete visualization and coverage from M2 to ICA.4,6
FOR SAFETY AND EFFICACY
Our Solitaire portfolio is backed by published data with 11+ trials and case studies worldwide, proving it reduces stroke-related disability in patients suffering a large vessel acute ischemic stroke following IV t-PA.9-19
ACUTE ISCHEMIC STROKE PORTFOLIO
Our AIS portfolio offers comprehensive, compatible solutions that give your patients a better chance to walk away from AIS.
- React™ 68 and React™ 71 Catheter
- Riptide™ Aspiration System
- Cello™ Balloon Guide Catheter*
See the Neurovascular Product Catalog(opens new window)
ECONOMIC VALUE DATA SUPPORTEDSee how stroke treatment with the Solitaire device provides economic value.
The Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvement in functional outcomes at 90 days in patients suffering LVO.1
WITH PRECISION YOU CAN SEE2
The Solitaire™ X portfolio is designed to give you greater confidence during interventional stroke procedures with:
- Unique Parametric design for dynamic clot integration3,4
- Differentiated radial outward force4,5
- Complete visualization and coverage from M2 to ICA4,6
- Optimized delivery system produces lower delivery force1,7 for procedural efficiency and smooth navigation
- Robust clinical evidence21